Tetraphase Pharmaceuticals, Inc.

Diana Katharine Hunt

Xiao-Yi Xiao

Roger B Clark

Louis Plamondon

Minsheng He

Robert Zahler

Jingye Zhou

Magnus Ronn

Cuixiang Sun

Wu-Yan Zhang

Joyce A Sutcliffe

Magnus Rönn

Trudy Grossman

Robert B Zahler

Joyce Sutcliffe

The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.

Tetracycline compounds

Tetracyline compounds

The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use. 

The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.

Polycyclic tetracycline compounds

The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

C7-fluoro substituted tetracycline compounds

Growing community of inventors

Cambridge, MA, United States of America

Diana Katharine Hunt